Skip to main content

Preeclampsia clinical trials at UCSD

2 in progress, 1 open to eligible people

Showing trials for
  • Multi-Omics for Maternal Health After Preeclampsia

    open to eligible females ages 18-50

    To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.

    San Diego, California

  • MIRACLE of LIFE Study

    Sorry, in progress, not accepting new patients

    The goal of this observational study is to develop and validate cell-free RNA-based biomarkers for predicting a variety of adverse pregnancy outcomes in a pregnant person population. The main question it aims to answer are: 1. Can cell-free RNA-based biomarkers predict which pregnant people are at greatest risk of developing adverse pregnancy outcomes (e.g., preterm birth, preeclampsia)? 2. What is the performance of such biomarkers when predicting an adverse pregnancy outcome (e.g., sensitivity, specificity, PPV, NPV, TPR)?

    San Diego, California and other locations

Our lead scientists for Preeclampsia research studies include .

Last updated: